Area of research
Surgery · Molecular Biology
Research interest
Research interests include Eosinophilic Esophagitis, Metabolomics and Mass Spectrometry Studies, IL-33, ST2, and ILC Pathways, and Heart Failure Treatment and Management.
Brain-derived extracellular vesicles as serologic markers of brain injury following cardiac arrest: A pilot feasibility study
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes
Distinct metabolomic signatures are associated with longevity in humans
Weight Loss, Saline Loading, and the Natriuretic Peptide System
Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study
Long‐term Cardiovascular Risks Associated With an Elevated Heart Rate: The Framingham Heart Study
Effect of Phosphodiesterase Inhibition on Insulin Resistance in Obese Individuals
Biomarkers of Cardiovascular Stress and Subclinical Atherosclerosis in the Community
2-Aminoadipic acid is a biomarker for diabetes risk
A Genome-wide Association Study of the Human Metabolome in a Community-Based Cohort
A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction
Metabolite Profiles During Oral Glucose Challenge
Atrial natriuretic peptide is negatively regulated by microRNA-425
Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling
Soluble ST2 predicts elevated SBP in the community
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress
Distribution and Clinical Correlates of the Interleukin Receptor Family Member Soluble ST2 in the Framingham Heart Study
Clinical and Genetic Correlates of Growth Differentiation Factor 15 in the Community